Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso
- Autores:
-
Benedetti Padrón, Inés
Barrios García, Lía
Arroyo Salgado, Bárbara
De Oro, Blanca
Beleño, José
Meza, Mauricio
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2010
- Institución:
- Universidad de Cartagena
- Repositorio:
- Repositorio Universidad de Cartagena
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.unicartagena.edu.co:11227/12870
- Acceso en línea:
- https://hdl.handle.net/11227/12870
https://doi.org/10.32997/rcb-2010-2719
- Palabra clave:
- Adenocarcinoma prostático
Células basales
34BE12
p63
- Rights
- openAccess
- License
- Revista Ciencias Biomédicas - 2020
id |
UCART2_8da3657e444cfeed4801b569a8025f97 |
---|---|
oai_identifier_str |
oai:repositorio.unicartagena.edu.co:11227/12870 |
network_acronym_str |
UCART2 |
network_name_str |
Repositorio Universidad de Cartagena |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso |
dc.title.translated.eng.fl_str_mv |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso |
title |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso |
spellingShingle |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso Adenocarcinoma prostático Células basales 34BE12 p63 |
title_short |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso |
title_full |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso |
title_fullStr |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso |
title_full_unstemmed |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso |
title_sort |
Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudoso |
dc.creator.fl_str_mv |
Benedetti Padrón, Inés Barrios García, Lía Arroyo Salgado, Bárbara De Oro, Blanca Beleño, José Meza, Mauricio |
dc.contributor.author.spa.fl_str_mv |
Benedetti Padrón, Inés Barrios García, Lía Arroyo Salgado, Bárbara De Oro, Blanca Beleño, José Meza, Mauricio |
dc.subject.spa.fl_str_mv |
Adenocarcinoma prostático Células basales 34BE12 p63 |
topic |
Adenocarcinoma prostático Células basales 34BE12 p63 |
publishDate |
2010 |
dc.date.accessioned.none.fl_str_mv |
2010-01-15 00:00:00 |
dc.date.available.none.fl_str_mv |
2010-01-15 00:00:00 |
dc.date.issued.none.fl_str_mv |
2010-01-15 |
dc.type.spa.fl_str_mv |
Artículo de revista |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.content.spa.fl_str_mv |
Text |
dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.local.eng.fl_str_mv |
Journal article |
format |
http://purl.org/coar/resource_type/c_6501 |
status_str |
publishedVersion |
dc.identifier.issn.none.fl_str_mv |
2215-7840 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/11227/12870 |
dc.identifier.doi.none.fl_str_mv |
10.32997/rcb-2010-2719 |
dc.identifier.eissn.none.fl_str_mv |
2389-7252 |
dc.identifier.url.none.fl_str_mv |
https://doi.org/10.32997/rcb-2010-2719 |
identifier_str_mv |
2215-7840 10.32997/rcb-2010-2719 2389-7252 |
url |
https://hdl.handle.net/11227/12870 https://doi.org/10.32997/rcb-2010-2719 |
dc.language.iso.spa.fl_str_mv |
spa |
language |
spa |
dc.relation.ispartofjournal.spa.fl_str_mv |
Revista Ciencias Biomédicas |
dc.relation.bitstream.none.fl_str_mv |
https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2719/2271 |
dc.relation.citationedition.spa.fl_str_mv |
Núm. 1 , Año 2010 |
dc.relation.citationendpage.none.fl_str_mv |
22 |
dc.relation.citationissue.spa.fl_str_mv |
1 |
dc.relation.citationstartpage.none.fl_str_mv |
10 |
dc.relation.citationvolume.spa.fl_str_mv |
1 |
dc.relation.references.spa.fl_str_mv |
Humphrey P A, Diagnosis of Adenocarcinoma in prostate needle biopsy tissue, J Cliical Pathology 2007, 60 :35-42 Parkin DM, Bray F, Ferlay J. et al., Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74–108 Registro de cáncer de Cali 1997, Instituto Nacional de Cancerología 1995-1999 American Cancer Society, Inc, Cancer Facts and Figures, Atlanta 2005 Chodak Gerald, Prostate cancer: epidemiology, screening and biomarkers, Reviews in Urology, Vol 8, Suppl2, S3-S8, 2006 Shah R.B., M. Zhou, M. LeBlanc, M. Snyder and M.A. Rubin, Comparison of the basal cellspecific markers, 34betaE12 and p63 in the diagnosis of prostate cancer, Am J Surg Pathol 26 (2002), pp. 1161–1168. Boccon-Gibod Liliane et al., Handling and Pathology Reporting of Prostate Biopsies, European Urology, Volume 46 Issue 2, Agosto 2004, Pág 177-181. czkowski A. Kenneth, MacLennan G, Bostwick D, Atypical Small Acinar Proliferation Suspicious for Malignancy in Prostate Needle Byopsies, The American journal of Surgical Pathology, 21(12) 1489-1495, 1997 Hameed Omar and Humphrey, Immunohistochemistry in the diagnosis of minimal prostate cancer Current diagnostic pathology, Vol 12, Issue 4, Agosto 2006, Pág. 279-291 Shah Rajal, Lakshmi P Kunju , Shen R, Leblanc M, Zhou M, Rubin M Usefulness of Basal Cell Cocktail (34BE12 + P63) in the Diagnosis of Atypical Prostate Glandular Proliferation, American Journal of Clinical Pathology, 2004; 122(4): 517-523 Collins Anne T. AND Maitland Norman J, Prostate cancer stem cells, Europen journal of cancer, Vol 42, Issue 9, Junio 2006, Pág 1213-1218. Hedrick Lora, Epstein J, Use of Keratin 903 as an Adjunct in the Diagnosis of Prostate Carcinoma, The American Journal of Surgical Pathology, 13(5): 389-396, 1989 Epstein J, Yang X, Prostate Biopsy Interpretation, 2002, Yan Gao Man, C Zhao, X Chen, A subset of prostate basal cell lacks the expression of corresponding phenotyping markers, Pathology Research and Practice 202 (2006) 651-662 Algaba F, Epstein JI, Aldape HC, et al., Assessment of prostate carcinoma in core needle biopsy—definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer 1996; 78:376–8 Montironi Rodolfo et al., 2005 Update on Pathology of Prostate Biopsies with Cancer, European Urology, Vol 49, Issue 3, Marzo 2006, pág 441-447. Totten RS, Heinemann MW, Hudson PB, et al.,Microscopic differential diagnosis of latent carcinoma of prostate. Arch Pathol 1953; 55:131–41. Gaudin Paul, Epstein J, Adenosis of the Prostate, The American Journal of Surgical Pathology 18 (9) 863-870, 1994 Varma M, Jasani B, Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature, Histopathology 2005, 47, 1-16 Hameed O, Humphrey PA. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 2005; 2:88–104 Zhou Ming, Magi-Galluzi C, Epstein J, Prostate basal cell lesions can be negative for Basal cell Keratins, Analytical and Quantitative Cytology and Histology, Vol 8, Number 3, June 2006 Brawer M.K., D.M. Peehl, T.A. Stamey and D.G. Bostwick, Keratin immunoreactivity in the benign and neoplastic human prostate, Cancer Res 45 (1985), pp. 3663–3667. Goldstein N.S., J. Underhill, J. Roszka and J.S. Neill, Cytokeratin 34betaE-12 immunoreactivity in benign prostatic acini: quantitation, pattern assessment, and electron microscopic study, Am J Clin Pathol 112 (1999), pp. 69–74. Gown A.M. and A.M. Vogel, Monoclonal antibodies to human intermediate filament proteins, II: distribution of filament proteins in normal human tissues, Am J Pathol 114 (1984), pp. 309–321. Helpap B, J. Kollermann and U. Oehler, Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry, J Pathol 193 (2001), pp. 350–353. Kahane H., J.W. Sharp, G.B. Shuman, G. Dasilva and J.I. Epstein, Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory, Urology 45 (1995), pp. 981–986. Okada H., A. Tsubura and A. Okamura et al., Keratin profiles in normal/hyperplastic prostates and prostate carcinoma, Virchows Arch A: Pathol Anat Histopathol 421 (1992), pp. 157–161. Samaratunga H. and M. Singh, Distribution pattern of basal cells detected by cytokeratin 34betaE12 in primary prostatic duct adenocarcinoma, Am J Surg Pathol 21 (1997), pp. 435–440 Shah I.A., M.O. Schlageter, P. Stinnett and J. Lechago, Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate, Mod Pathol 4 (1991), pp. 220–224. Shin M., M.Q. Fujita, Y. Yasunaga, T. Miki, A. Okuyama and K. Aozasa, Utility of immunohistochemical detection of high molecular weight cytokeratin for differential diagnosis of proliferative conditions of the prostate, Int J Urol 5 (1998), pp. 237–242. Wojno K.J. and J.I. Epstein, The utility of basal cell-specific anti-cytokeratin antibody (34betaE12) in the diagnosis of prostate cancer: a review of 228 cases, Am J Surg Pathol 19 (1995), pp. 251–260. Zhou M., Z. Jiang and J.I. Epstein, Expression and diagnostic utility of alpha-methylacyl-CoAracemase (P504S) in foamy gland and pseudohyperplastic prostate cancer, Am J Surg Pathol 27 (2003), pp. 772–778 Davis L.D, W. Zhang and A. Merseburger et al., p63 expression profile in normal and malignant prostate epithelial cells, Anticancer Res 22 (2002), pp. 3819–3825 Molinie V., G. Fromont and M. Sibony et al., Diagnostic utility of a p63 alpha-methyl-CoAracemase (p504s) cocktail in atypical foci in the prostate, Mod Pathol 17 (2004), pp. 1180–1190 Weinstein M.H., S. Signoretti and M. Loda, Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells, Mod Pathol 15 (2002), pp. 1302–1308 Wu H.H., O. Lapkus and M. Corbin, Comparison of 34betaE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies, Appl Immunohistochem Mol Morphol 12 (2004), pp. 285–289. Zhou Ming, Shah R, Shen R, Rubin M, Basal Cell Cocktail (34BE12+P63) improves the detection of Prostate Basal Cells, The American Journal of Surgical Pathology 27(3) 365-371, 2003 Ute M. Moll et al., p53, p63 and p73 – solos, alliances and feuds among family members , Biochimica et biophysica acta, volume 1552 isuue 2:47-59 december 2001 Ferdinandusse S, S. Denis, L. IJlst, G. Dacremont, H.R. Waterham and R.J. Wanders, Subcellular localization and physiological role of alpha-methylacyl-CoA racemase, J Lipid Res 41 (2000), pp. 1890–1896. Xu J, J.A. Stolk and X. Zhang et al., Identification of differentially expressed genes in human prostate cancer using subtraction and microarray, Cancer Res 60 (2000), pp. 1677–1682. Zhou M., A.M. Chinnaiyan, C.G. Kleer, P.C. Lucas and M.A. Rubin, Alpha-methylacyl-coA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions, Am J Surg Pathol 26 (2002), pp. 926–931. Beach R, A.M. Gown and M.N. De Peralta-Venturina et al., P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies, Am J Surg Pathol 26 (2002), pp. 1588–1596 Farinola M.A., and J.I. Epstein, Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy, Hum Pathol 35 (2004), pp. 1272–1278 Jiang Z., C. Li, A. Fischer, K. Dresser and B.A. Woda, Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens, Am J Clin Pathol 123 (2005), pp. 231–236 Jiang Z., C.L. Wu and B.A. Woda et al., P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy, Am J Surg Pathol 26 (2002), pp. 1169–1174 Kunju L.P, M.A. Rubin, A.M. Chinnaiyan and R.B. Shah, Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations, Am J Clin Pathol 120 (2003), pp. 737-745.. Magi-Galluzzi C., J. Luo, W.B. Isaacs, J.L. Hicks, A.M. de Marzo and J.I. Epstein, Alphamethylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy, Am J Surg Pathol 27 (2003), pp. 1128–1133 Browne T.J., M.S. Hirsch, G. Brodsky, W.R. Welch, M.F. Loda and M.A. Rubin, Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens, Hum Pathol 35 (2004), pp. 1462–1468 Zhou M., H. Aydin, H. Kanane and J.I. Epstein, How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?, Am J Surg Pathol 28 (2004), pp. 239–243 Andres M.W., M.A. Amin, T. Freidman, R. Malhotra and A.R. Prasad, Characterization of small foci of atypical glands in prostate needle biopsies using double immunostaining with polyclonal α-methylacyl-CoA racemase and high molecular weight cytokeratin, Mod Pathol 17 (2004), p. 138A. Halushka Marc K. MD, PhD, Negative 34βE12 staining in a small focus of atypical glands on prostate needle biopsy: a follow-up study of 332 cases , Human Pathology, Vol 35, Issue 1,Enero 2004, pág 43-46 Jiang Z., C.L. Wu and B.A. Woda et al., Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker, Histopathology 45 (2004), pp. 218–225. Jiang Z., B.A. Woda and K.L. Rock et al., P504S: a new molecular marker for the detection of prostate carcinoma, Am J Surg Pathol 25 (2001), pp. 1397–1404 Ming-Tse Sung MD et al., α-methylacyl-CoA racemase (P504S)/34βE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy, Human Pathology, Vol 38, Issue 2, Febrero 2007, Pág 332-341. Jiang Z., K.A. Iczkowski, B.A. Woda, M. Tretiakova and X.J. Yang, P504S immunostaining boosts diagnostic resolution of “suspicious” foci in prostatic needle biopsy specimens, Am J Clin Pathol 121 (2004), pp. 99–107 Varma M, M.D. Linden and M.B. Amin, Effect of formalin fi xation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues, Mod Pathol 12 (1999), pp. 472–478 Green R, and Epstein J, Use of intervening unstained slides for inmunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies,,Am J Surg Pathol 1999,23 (5): 567-570 Van Der Kwast et al, Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies, (Am J Surg Pathol 2010; 34: 169–177 O’Malley F.P., D.J. Grignon and D.T. Shum, Usefulness of immunoperoxidase staining with highmolecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland, Virchows Arch A: Pathol Anat Histopathol 417 (1990), pp. 191–196. |
dc.rights.spa.fl_str_mv |
Revista Ciencias Biomédicas - 2020 |
dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Revista Ciencias Biomédicas - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Universidad de Cartagena |
dc.source.spa.fl_str_mv |
https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2719 |
institution |
Universidad de Cartagena |
bitstream.url.fl_str_mv |
https://repositorio.unicartagena.edu.co/bitstreams/803759ba-b05c-421d-89c3-84dc99a787ce/download |
bitstream.checksum.fl_str_mv |
f943a8114b300db476d42be9b623a334 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
repository.name.fl_str_mv |
Biblioteca Digital Universidad de Cartagena |
repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
_version_ |
1814214177044037632 |
spelling |
Benedetti Padrón, InésBarrios García, LíaArroyo Salgado, BárbaraDe Oro, BlancaBeleño, JoséMeza, Mauricio2010-01-15 00:00:002010-01-15 00:00:002010-01-152215-7840https://hdl.handle.net/11227/1287010.32997/rcb-2010-27192389-7252https://doi.org/10.32997/rcb-2010-2719application/pdfspaUniversidad de CartagenaRevista Ciencias Biomédicashttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2719/2271Núm. 1 , Año 2010221101Humphrey P A, Diagnosis of Adenocarcinoma in prostate needle biopsy tissue, J Cliical Pathology 2007, 60 :35-42Parkin DM, Bray F, Ferlay J. et al., Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74–108Registro de cáncer de Cali 1997, Instituto Nacional de Cancerología 1995-1999American Cancer Society, Inc, Cancer Facts and Figures, Atlanta 2005Chodak Gerald, Prostate cancer: epidemiology, screening and biomarkers, Reviews in Urology, Vol 8, Suppl2, S3-S8, 2006Shah R.B., M. Zhou, M. LeBlanc, M. Snyder and M.A. Rubin, Comparison of the basal cellspecific markers, 34betaE12 and p63 in the diagnosis of prostate cancer, Am J Surg Pathol 26 (2002), pp. 1161–1168.Boccon-Gibod Liliane et al., Handling and Pathology Reporting of Prostate Biopsies, European Urology, Volume 46 Issue 2, Agosto 2004, Pág 177-181.czkowski A. Kenneth, MacLennan G, Bostwick D, Atypical Small Acinar Proliferation Suspicious for Malignancy in Prostate Needle Byopsies, The American journal of Surgical Pathology, 21(12) 1489-1495, 1997Hameed Omar and Humphrey, Immunohistochemistry in the diagnosis of minimal prostate cancer Current diagnostic pathology, Vol 12, Issue 4, Agosto 2006, Pág. 279-291Shah Rajal, Lakshmi P Kunju , Shen R, Leblanc M, Zhou M, Rubin M Usefulness of Basal Cell Cocktail (34BE12 + P63) in the Diagnosis of Atypical Prostate Glandular Proliferation, American Journal of Clinical Pathology, 2004; 122(4): 517-523Collins Anne T. AND Maitland Norman J, Prostate cancer stem cells, Europen journal of cancer, Vol 42, Issue 9, Junio 2006, Pág 1213-1218.Hedrick Lora, Epstein J, Use of Keratin 903 as an Adjunct in the Diagnosis of Prostate Carcinoma, The American Journal of Surgical Pathology, 13(5): 389-396, 1989Epstein J, Yang X, Prostate Biopsy Interpretation, 2002,Yan Gao Man, C Zhao, X Chen, A subset of prostate basal cell lacks the expression of corresponding phenotyping markers, Pathology Research and Practice 202 (2006) 651-662Algaba F, Epstein JI, Aldape HC, et al., Assessment of prostate carcinoma in core needle biopsy—definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer 1996; 78:376–8Montironi Rodolfo et al., 2005 Update on Pathology of Prostate Biopsies with Cancer, European Urology, Vol 49, Issue 3, Marzo 2006, pág 441-447.Totten RS, Heinemann MW, Hudson PB, et al.,Microscopic differential diagnosis of latent carcinoma of prostate. Arch Pathol 1953; 55:131–41.Gaudin Paul, Epstein J, Adenosis of the Prostate, The American Journal of Surgical Pathology 18 (9) 863-870, 1994Varma M, Jasani B, Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature, Histopathology 2005, 47, 1-16Hameed O, Humphrey PA. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 2005; 2:88–104Zhou Ming, Magi-Galluzi C, Epstein J, Prostate basal cell lesions can be negative for Basal cell Keratins, Analytical and Quantitative Cytology and Histology, Vol 8, Number 3, June 2006Brawer M.K., D.M. Peehl, T.A. Stamey and D.G. Bostwick, Keratin immunoreactivity in the benign and neoplastic human prostate, Cancer Res 45 (1985), pp. 3663–3667.Goldstein N.S., J. Underhill, J. Roszka and J.S. Neill, Cytokeratin 34betaE-12 immunoreactivity in benign prostatic acini: quantitation, pattern assessment, and electron microscopic study, Am J Clin Pathol 112 (1999), pp. 69–74.Gown A.M. and A.M. Vogel, Monoclonal antibodies to human intermediate filament proteins, II: distribution of filament proteins in normal human tissues, Am J Pathol 114 (1984), pp. 309–321.Helpap B, J. Kollermann and U. Oehler, Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry, J Pathol 193 (2001), pp. 350–353.Kahane H., J.W. Sharp, G.B. Shuman, G. Dasilva and J.I. Epstein, Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory, Urology 45 (1995), pp. 981–986.Okada H., A. Tsubura and A. Okamura et al., Keratin profiles in normal/hyperplastic prostates and prostate carcinoma, Virchows Arch A: Pathol Anat Histopathol 421 (1992), pp. 157–161.Samaratunga H. and M. Singh, Distribution pattern of basal cells detected by cytokeratin 34betaE12 in primary prostatic duct adenocarcinoma, Am J Surg Pathol 21 (1997), pp. 435–440Shah I.A., M.O. Schlageter, P. Stinnett and J. Lechago, Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate, Mod Pathol 4 (1991), pp. 220–224.Shin M., M.Q. Fujita, Y. Yasunaga, T. Miki, A. Okuyama and K. Aozasa, Utility of immunohistochemical detection of high molecular weight cytokeratin for differential diagnosis of proliferative conditions of the prostate, Int J Urol 5 (1998), pp. 237–242.Wojno K.J. and J.I. Epstein, The utility of basal cell-specific anti-cytokeratin antibody (34betaE12) in the diagnosis of prostate cancer: a review of 228 cases, Am J Surg Pathol 19 (1995), pp. 251–260.Zhou M., Z. Jiang and J.I. Epstein, Expression and diagnostic utility of alpha-methylacyl-CoAracemase (P504S) in foamy gland and pseudohyperplastic prostate cancer, Am J Surg Pathol 27 (2003), pp. 772–778Davis L.D, W. Zhang and A. Merseburger et al., p63 expression profile in normal and malignant prostate epithelial cells, Anticancer Res 22 (2002), pp. 3819–3825Molinie V., G. Fromont and M. Sibony et al., Diagnostic utility of a p63 alpha-methyl-CoAracemase (p504s) cocktail in atypical foci in the prostate, Mod Pathol 17 (2004), pp. 1180–1190Weinstein M.H., S. Signoretti and M. Loda, Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells, Mod Pathol 15 (2002), pp. 1302–1308Wu H.H., O. Lapkus and M. Corbin, Comparison of 34betaE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies, Appl Immunohistochem Mol Morphol 12 (2004), pp. 285–289.Zhou Ming, Shah R, Shen R, Rubin M, Basal Cell Cocktail (34BE12+P63) improves the detection of Prostate Basal Cells, The American Journal of Surgical Pathology 27(3) 365-371, 2003Ute M. Moll et al., p53, p63 and p73 – solos, alliances and feuds among family members , Biochimica et biophysica acta, volume 1552 isuue 2:47-59 december 2001Ferdinandusse S, S. Denis, L. IJlst, G. Dacremont, H.R. Waterham and R.J. Wanders, Subcellular localization and physiological role of alpha-methylacyl-CoA racemase, J Lipid Res 41 (2000), pp. 1890–1896.Xu J, J.A. Stolk and X. Zhang et al., Identification of differentially expressed genes in human prostate cancer using subtraction and microarray, Cancer Res 60 (2000), pp. 1677–1682.Zhou M., A.M. Chinnaiyan, C.G. Kleer, P.C. Lucas and M.A. Rubin, Alpha-methylacyl-coA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions, Am J Surg Pathol 26 (2002), pp. 926–931.Beach R, A.M. Gown and M.N. De Peralta-Venturina et al., P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies, Am J Surg Pathol 26 (2002), pp. 1588–1596Farinola M.A., and J.I. Epstein, Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy, Hum Pathol 35 (2004), pp. 1272–1278Jiang Z., C. Li, A. Fischer, K. Dresser and B.A. Woda, Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens, Am J Clin Pathol 123 (2005), pp. 231–236Jiang Z., C.L. Wu and B.A. Woda et al., P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy, Am J Surg Pathol 26 (2002), pp. 1169–1174Kunju L.P, M.A. Rubin, A.M. Chinnaiyan and R.B. Shah, Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations, Am J Clin Pathol 120 (2003), pp. 737-745..Magi-Galluzzi C., J. Luo, W.B. Isaacs, J.L. Hicks, A.M. de Marzo and J.I. Epstein, Alphamethylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy, Am J Surg Pathol 27 (2003), pp. 1128–1133Browne T.J., M.S. Hirsch, G. Brodsky, W.R. Welch, M.F. Loda and M.A. Rubin, Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens, Hum Pathol 35 (2004), pp. 1462–1468Zhou M., H. Aydin, H. Kanane and J.I. Epstein, How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?, Am J Surg Pathol 28 (2004), pp. 239–243Andres M.W., M.A. Amin, T. Freidman, R. Malhotra and A.R. Prasad, Characterization of small foci of atypical glands in prostate needle biopsies using double immunostaining with polyclonal α-methylacyl-CoA racemase and high molecular weight cytokeratin, Mod Pathol 17 (2004), p. 138A.Halushka Marc K. MD, PhD, Negative 34βE12 staining in a small focus of atypical glands on prostate needle biopsy: a follow-up study of 332 cases , Human Pathology, Vol 35, Issue 1,Enero 2004, pág 43-46Jiang Z., C.L. Wu and B.A. Woda et al., Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker, Histopathology 45 (2004), pp. 218–225.Jiang Z., B.A. Woda and K.L. Rock et al., P504S: a new molecular marker for the detection of prostate carcinoma, Am J Surg Pathol 25 (2001), pp. 1397–1404Ming-Tse Sung MD et al., α-methylacyl-CoA racemase (P504S)/34βE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy, Human Pathology, Vol 38, Issue 2, Febrero 2007, Pág 332-341.Jiang Z., K.A. Iczkowski, B.A. Woda, M. Tretiakova and X.J. Yang, P504S immunostaining boosts diagnostic resolution of “suspicious” foci in prostatic needle biopsy specimens, Am J Clin Pathol 121 (2004), pp. 99–107Varma M, M.D. Linden and M.B. Amin, Effect of formalin fi xation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues, Mod Pathol 12 (1999), pp. 472–478Green R, and Epstein J, Use of intervening unstained slides for inmunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies,,Am J Surg Pathol 1999,23 (5): 567-570Van Der Kwast et al, Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies, (Am J Surg Pathol 2010; 34: 169–177O’Malley F.P., D.J. Grignon and D.T. Shum, Usefulness of immunoperoxidase staining with highmolecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland, Virchows Arch A: Pathol Anat Histopathol 417 (1990), pp. 191–196.Revista Ciencias Biomédicas - 2020https://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccesshttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2719Adenocarcinoma prostáticoCélulas basales34BE12p63Determinación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudosoDeterminación retrospectiva de marcadores de células basales útiles en el diagnóstico del adenocarcinoma prostático en biopsias prostáticas con diagnóstico dudosoArtículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articleJournal articlePublicationOREORE.xmltext/xml2712https://repositorio.unicartagena.edu.co/bitstreams/803759ba-b05c-421d-89c3-84dc99a787ce/downloadf943a8114b300db476d42be9b623a334MD5111227/12870oai:repositorio.unicartagena.edu.co:11227/128702024-09-05 15:30:42.48https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Ciencias Biomédicas - 2020metadata.onlyhttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.com |